トランスファーリン受容体1は,日本脳炎ウイルスの侵入因子である
Qing Yang1, Shengda Xie1, Yundi Zhao1
1MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.
Veterinary microbiology
|September 2, 2025
まとめ
日本脳炎ウイルス (JEV) は,トランスファーリン受容体1 (TfR1) を使用して細胞に侵入します. フェリックアンモニアムシトラート (FAC) のような鉄サプリメントでTfR1を抑制することは,JEV感染に対する潜在的な抗ウイルス戦略を提供します.
科学分野:
- ウイルス学
- 細胞生物学
- 感染症
背景:
- 日本脳炎ウイルス (JEV) は,人間と動物のウイルス性脳炎を引き起こす.
- JEVの侵入メカニズムを理解することは,抗ウイルス治療の開発に不可欠です.
研究 の 目的:
- JEV感染におけるトランスファーリン受容体1 (TfR1) の役割を調査する.
- JEVの潜在的な抗ウイルス標的としてTfR1を特定する.
主な方法:
- A549,HeLa,および293T細胞におけるTfR1のノックダウンと過剰発現.
- JEV Eタンパク質とTfR1の相互作用を調査した.
- 溶解可能なhTfR1エクトドメインタンパク質とフェリックアンモニアムシトラート (FAC) をJEV感染を阻害するために使用した.
主要な成果:
- TfR1のノックダウンが JEVの侵入を阻害し,過剰発現がそれを強化した.
- JEV Eタンパク質は,特にTfR1残基384- 606と相互作用する.
- 溶性TfR1はJEV感染を阻害し,FACはTfR1の発現を抑制し,JEVの侵入と感染を抑制した.
結論:
- TfR1はJEVの重要なエントリー因子として特定されています.
- TfR1はJEVにとって有望な抗ウイルス標的です.
- FACのような小分子阻害剤は JEVに対する抗ウイルス戦略として潜在性を示しています
関連する概念動画
The Early Endosome: Endocytosis of Transferrin
3.4K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.4K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Receptor-mediated Endocytosis
6.3K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.3K
Enzyme-linked Receptors
79.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
79.9K


